Fulvestrant Accord 250 mg/5 ml, Injektionslösung in einer Fertigspritze
7680675650026
CH-67565
Injektionslösung
Associated product:
FULVESTRANT Accord 250 mg/5ml ser pré 2 pce
1 / 2
google
Article details
- Package size
- 2
- Selling units
- 2
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
500.0 MG | Substance | HBESI |
|
(N/A)
|
500.0 MG | Substance | HBESI |
|
(N/A)
|
750.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 329.05
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/03/2021
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 67565
- Drug name
- Fulvestrant Accord, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L02BA03
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 11/08/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.2.
- Domain
- Human medicine
Package details
- Description (FR)
- FULVESTRANT Accord 250 mg/5ml ser pré 2 pce
- Description (DE)
- FULVESTRANT Accord 250 mg/5ml Fertspr 2 Stk
- Market launch
- 11/08/2020
- Narcotic (BTM)
- No
Original drug
Faslodex, Injektionslösung
GTIN: 7680567780121
CHF 379.80
Other package sizes (1)
None
1 FESP
GTIN: None